| | | | | |
| $31,7150 | -0,05% | $280,50M | $80,52K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0900 | +0,00% | $280,16M | $33,47K | |
TSI TCW Strategic Income Fund, Inc. | $4,3600 | -0,34% | $279,70M | $325,54K | |
PAII Pyrophyte Acquisition Corp. II | $10,2800 | +0,20% | $279,21M | $4,78K | |
| $14,6200 | +0,00% | $279,07M | $361,49K | |
YDES YD Bio Limited Ordinary Shares | $4,9100 | +2,59% | $279,07M | $36,00K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9890 | -0,01% | $278,71M | $109,74K | |
RWAY Runway Growth Finance Corp. Common Stock | $6,6350 | +0,53% | $278,70M | $506,53K | |
JILL J.Jill, Inc. Common Stock | $20,2100 | -0,54% | $278,69M | $66,00K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0800 | +0,00% | $278,19M | $716,42K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | +0,05% | $278,12M | $23,90K | |
ACV Virtus Diversified Income & Convertible Fund | $26,3300 | -1,27% | $278,09M | $21,50K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $2,0350 | +2,26% | $277,93M | $410,88K | |
| $1,4300 | +5,93% | $277,83M | $1,14M | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,0000 | +0,67% | $277,66M | $63,42K | |
